Archives

Impact of Patient Assistance Programs on Out-of-Pocket Costs for Oral Oncolytics Managed Through Integrated Health System Specialty Pharmacies 216 115 Shields Health Solutions

Impact of Patient Assistance Programs on Out-of-Pocket Costs for Oral Oncolytics Managed Through Integrated Health System Specialty Pharmacies

This poster highlights the impact of an HSSP model on accessing Patient Assistance Program (PAP) funding for oral oncolytic drugs. Government-insured patients received PAP support more often with brand medications…

Hospital Utilization Rates for Oncology Patients in an Integrated Health System Compared to a National Network 216 115 Shields Health Solutions

Hospital Utilization Rates for Oncology Patients in an Integrated Health System Compared to a National Network

This poster highlights how HSSP oncology patients had lower hospital utilization rates compared to a national network, indicating the potential for avoidable medical events. Implementing an integrated care model with…

Clinical and Quality Outcomes of a Hypertrophic Cardiomyopathy Management Program within an Integrated Health System Specialty Pharmacy Model 216 115 Shields Health Solutions

Clinical and Quality Outcomes of a Hypertrophic Cardiomyopathy Management Program within an Integrated Health System Specialty Pharmacy Model

This poster spotlights our collaboration with NYULangone Health and highlights how the success of an ambulatory pharmacist-led program within an HSSP in efficiently handling mavacamten therapy and REMS program requirements…

Impact of an Ambulatory Clinical Pharmacist on Oral Oncolytics in a Hematology/Oncology Specialty Clinic Integrated with a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Impact of an Ambulatory Clinical Pharmacist on Oral Oncolytics in a Hematology/Oncology Specialty Clinic Integrated with a Health System Specialty Pharmacy

This poster highlights the positive impact of introducing ACP services into a hematology/oncology clinic, leading to successful outcomes and substantial cost savings following HSSP integration. Challenges in cost estimation stemmed…

Implementation of Ambulatory Clinical Pharmacist Type 2 Diabetes Care Services Within an Integrated Health-System Specialty Pharmacy 216 115 Shields Health Solutions

Implementation of Ambulatory Clinical Pharmacist Type 2 Diabetes Care Services Within an Integrated Health-System Specialty Pharmacy

This poster spotlights our collaboration with NYULangone Health and highlights how the integration of ACP-let medication management services, specializing in diabetes care, into an integrated HSSP results in markedly improved…

Impact of Integrating a Pharmacy Liaison-Managed Care Model within a Diabetes Population 216 115 Shields Health Solutions

Impact of Integrating a Pharmacy Liaison-Managed Care Model within a Diabetes Population

This poster spotlights our collaboration with Berkshire Health Systems and highlights how implementing a pharmacy liaison-managed diabetes care model resulted in positive patient outcomes, including increased medication adherence, a 0.8%…

Achieving Accreditation of Health System Specialty Pharmacies Through a Standardized Method 216 115 Shields Health Solutions

Achieving Accreditation of Health System Specialty Pharmacies Through a Standardized Method

This poster spotlights Shields’ standardized method for achieving specialty pharmacy dual accreditation and reaccreditation through the following five categories: outreach, develop and review, track progress, manage and maintain, and prepare.

Shields Health Solutions Consistently Demonstrates Superior Clinical Outcomes 204 115 Shields Health Solutions

Shields Health Solutions Consistently Demonstrates Superior Clinical Outcomes

STOUGHTON, Mass.–(BUSINESS WIRE)–Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, recently published its latest patient outcomes in key disease states such as hepatitis C, HIV, rheumatoid arthritis (RA),…

PAH Care Model Provides a Road Map for Rare Disease Treatment 204 115 Shields Health Solutions

PAH Care Model Provides a Road Map for Rare Disease Treatment

The Shields Health Solutions care model for helping pharmacies and providers treat patients with pulmonary arterial hypertension (PAH) integrates a patient’s entire care team, and can be adopted to successfully…

How Specialty Pharmacy Can Support Value-Based Care and Population Health 204 115 Shields Health Solutions

How Specialty Pharmacy Can Support Value-Based Care and Population Health
This white paper discusses how expanding integrated health system specialty pharmacy can be an impactful tool that health systems can leverage to improve their performance under value-based care contracts.